Aix Scientifics   Report issue

For profit Phase 2 Phase 3
Founded: Aachen Germany (1996)

Organization Overview

First Clinical Trial
2011
NCT01416493
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now